Acetazolamide
- Product NDC
- 68071-3728
- 11-digit product format
- 680713728
- Labeler code
- 68071
- Product ID
- 68071-3728_27888b41-786a-8b5f-e063-6394a90adb98
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acetazolamide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticlas, Inc.
- Application
- ANDA209734
- Marketing category
- ANDA
- Marketing start
- 2017-11-20
- Substance
- ACETAZOLAMIDE
- Active strength
- 125 mg/1
- Pharmacologic classes
- Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Acetazolamide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ACETAZOLAMIDE | 125 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O3FX965V0I |
| Rxcui | 197303 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-3728-1 | Acetazolamide | 12 in 1 BOTTLE | TABLET | 12 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-3728 | ACETAZOLAMIDE TABLET [NUCARE PHARMACEUTICLAS, INC.] | 1 | Current NDC, 1 package rows | 20241124_278878bc-da9c-09d4-e063-6394a90abaf7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68071-3728-1 | 68071372801 | 12 TABLET in 1 BOTTLE (68071-3728-1) | 12 tablet | 2024-11-22 | No | No | Current |